Search the Newsreel

PetMed Express (PETS) Stock Falls on Q1 2027 Earnings

PetMed Express (PETS) reported a challenging first quarter of fiscal 2027 with a 19.9% revenue decrease, widened operating loss, and a net loss, causing its stock to fall 6.4%. Insider trading activity shows one purchase of 25,000 shares, while hedge funds largely decreased their …

PetMed Express (PETS) grants 60,000 restricted shares to interim CEO Campbell

PetMed Express (PETS) has granted its Interim CEO and President, Leslie C.G. Campbell, 60,000 restricted shares of common stock. This award, made under the 2024 Omnibus Incentive Plan, vests fully on the first anniversary of the grant date, subject to continued employment and specific …

PetMed: Fiscal Q1 Earnings Snapshot

This article is a placeholder for an earnings snapshot for PetMed. It indicates that fiscal Q1 earnings information is expected, but the content itself is currently empty.

PetMed Express earnings missed by $0.40, revenue fell short of estimates

PetMed Express GAAP EPS of -$0.28 misses by $0.40, revenue of $41.02M

* PetMed Express press release [https://seekingalpha.com/pr/20619131-petmeds-announces-first-quarter-financial-results] (PETS [https://seekingalpha.com/symbol/PETS]): Q1 GAAP EPS of -$0.28 misses by $0.40. * Revenue of $41.02M (-19.9% Y/Y). MORE ON PETMED EXPRESS * PetMed Express, Inc. (PETS) Q4 2026 Earnings Call Prepared Remarks Transcript [https://seekingalpha.com/article/4911174-petmed-express-inc-pets-q4-2026-earnings-call-prepared-remarks-transcript] * PetMed Express: High-Risk Turnaround, …

Renaissance Technologies reports 5.29% PetMed Express (PETS) ownership stake in updated filing

Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have reported a 5.29% beneficial ownership stake in PetMed Express (PETS), totaling 1,131,230 shares of common stock as of June 30, 2026. This updated filing, a Schedule 13G/A, indicates that the entities hold sole voting and …

PetMed Express (PETS) grants director Peter Batushansky 55,555 restricted shares

PetMed Express (PETS) director Peter Batushansky was granted 55,555 restricted shares of common stock under the company's 2024 Omnibus Incentive Plan. These shares will fully vest on August 11, 2027, provided he continues his service on the Board of Directors, bringing his total direct …

PetMed Express (PETS) awards 55,555-share restricted stock grant to director Mennen

PetMed Express (PETS) has awarded director Justin L. Mennen a restricted stock grant of 55,555 shares of common stock under the company's 2024 Omnibus Incentive Plan. These shares will fully vest on August 11, 2027, provided Mennen continues his service on the Board of …

PetMed Express, Inc. expected to post earnings of 12 cents a share - Earnings Preview

PetMed Express, Inc. is projected to report earnings of 12 cents per share. This information is presented as an earnings preview from Reuters, indicating an upcoming financial announcement for the company.

PetMed Express Trades Like A Bargain, But Losses Persist

PetMed Express (NASDAQ: PETS), an online pet pharmacy, is experiencing significant losses and declining sales, leading to its stock trading at a deep discount of around $1.96 per share. Despite the low valuation and a recent unsolicited acquisition proposal of $3.00 per share, the …

PetMed Express, Inc. (PETS) Stock Price, News, Quote & History

This Yahoo Finance page provides a comprehensive overview of PetMed Express, Inc. (PETS) stock, including its current price, historical data, financial performance, and analyst insights. The company operates as a pet pharmacy in the United States, offering a range of prescription and non-prescription pet …

Petmed Express Inc (PETS) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Petmed Express Inc (PETS), detailing its current earnings forecast score, average price target, and analyst rating. It highlights that the company ranks 19th out of 29 in its industry with a "Sell" rating from one analyst, and …

PETS Q1'26 Earnings: revenue estimate is 71.00M USD

PetMed Express, Inc. (PETS) is expected to release its Q1'26 earnings on August 13, after market close, with an estimated revenue of $71.00 million and EPS of $0.12. The article provides a detailed table comparing historical reported and estimated revenue and EPS figures from …

PetMed Express Inc (NASDAQ: PETS) Share Price, PETS Stock News, PETS Share Price & Updates

This article provides detailed financial data and company information for PetMed Express Inc (NASDAQ: PETS), including its stock performance, fundamentals, and recent financial results. It highlights a partnership with Dutch for accessible telehealth services for pets and offers a comprehensive overview of the company's …

PetMed Express (PETS) Gains 1.28% to $1.98, Edges Toward Resistance at $2.08 - Oversold Bounce Ideas

Pets at Home Group (LON:PETS) Earns "Buy" Rating from Deutsche Bank Aktiengesellschaft

PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026

PetMed Express, Inc. (Nasdaq: PETS) announced that it will report its financial results for the first quarter of fiscal year 2027, which ended June 30, 2026, on Thursday, August 13, 2026, after the market closes. The company will also host a conference call and …

PetMed Express to announce Q1 FY2027 results on August 13 after market close

PetMed Express will report its first-quarter fiscal year 2027 financial results on August 13, 2026, after the market closes. The online pet pharmacy will host a conference call and webcast at 4:30 PM Eastern Time to discuss these results. A replay of the call …

PetMeds sets 4:30 p.m. webcast to review first-quarter results

PetMed Express (NASDAQ: PETS) announced it will release its financial results for the first quarter of fiscal year 2027, covering the period ended June 30, 2026,

Petmed Express Inc (PETS) Institutional Confidence

This article analyzes the institutional confidence in Petmed Express Inc (PETS), showing its current institutional shareholding score and ranking within the Food & Drug Retailing industry. It details the latest institutional shareholding proportion, the largest institutional shareholder (James Simons), and a list of key …

Earnings Flash (PETS.L) Pets at Home Group Reports Fiscal Q1 Revenue GBP614.0M

PetMed Express, Inc. Revenue Breakdown – LSX:121843

PetMed Express, Inc. (LSX:121843) generated €154.95 million in revenue last year, with its Reorder segment contributing the most at €127.91 million. The United States was the primary regional contributor, accounting for all reported revenue. This indicates a focus on the U.S. market and recurring …

Pets at Home Group Plc Finalizes Purchase of 980,000 Shares in Latest £0.01 Ordinary Share Buyback

Petmed Express Inc (PETS) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical overview of Petmed Express Inc (PETS) dividends and stock splits. It details cash dividend payouts from May 2021 to August 2023, specifying the dividend amount, record date, payment date, and ex-dividend date for each. The data indicates that PETS …

Petmed Express Inc (PETS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Petmed Express Inc (PETS), focusing on its business segments. Key revenue contributions for FY2026Q3 show that reorder sales account for the vast majority (83.67%) of revenue, followed by new order sales (12.37%), and membership fees (3.96%). Regional …

PETS|Petmed Express Inc|Price:1.990|Chg%:-0.060

Petmed Express Inc (PETS) closed at $1.99, down 2.93% on July 24, 2026. The company, a direct-to-consumer pet pharmacy, shows strong fundamentals and high growth potential but is considered fairly valued with analysts rating it as "Sell." Its stock price is expected to trend …

PetMed Express (NASDAQ: PETS) awards stock and PSUs to interim CFO

PetMed Express (NASDAQ: PETS) has awarded interim CFO Douglas Krulik 32,500 restricted common shares and 32,500 performance share units (PSUs). The restricted shares vest 50% on June 26, 2027, and 50% on June 26, 2028, contingent on continued employment. The PSUs are tied to …

PetMed Express, Inc. (PETS) stock price, news, quote and history

PetMed Express, Inc. (PETS) stock closed at $1.99, down 2.93% on July 24, 2026, with an after-hours price of $1.9013. The company, a pet pharmacy providing prescription and non-prescription medications and supplies, has seen significant negative returns over the past year and five years, …

PetMed Express To Sell Delray Beach Headquarters For $37 Million In Sale-Leaseback With Redfearn

PetMed Express is selling its Delray Beach headquarters for $37 million in a sale-leaseback agreement with Redfearn Capital Acquisitions. The deal involves leasing back the 100,519-square-foot property for an initial 10-year term, with options for extension. This move aims to monetize real estate assets …

PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million

PetMed Express, Inc. (Nasdaq: PETS) has entered into a definitive agreement for a sale-leaseback transaction of its headquarters and distribution center buildings in Delray Beach, FL, for an aggregate purchase price of $37 million. This move aims to strengthen the company's balance sheet, optimize …

PetMed Express (PETS) Executes $37 Million Sale-Leaseback Deal

PetMed Express (PETS) has finalized a $37 million sale-leaseback agreement for its headquarters and distribution facilities in Delray Beach, Florida. This strategic move aims to unlock capital and improve liquidity, with the transaction expected to close within four months. Despite facing financial challenges, reflected …

PetMeds' $37M property deal would keep its Florida offices

PetMed Express (NASDAQ: PETS) announced a definitive agreement for a $37 million sale-leaseback transaction involving its headquarters and distribution center in Delray Beach, Florida. This move aims to strengthen its balance sheet, optimize assets, and unlock real estate value, while allowing the company to …